Navigation Links
Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology

ES versus ReoproR-BMS in the prevention of the cumulative incidence of death, MI, and TVR in acute myocardial infarction patients. The results from MULTI-STRATEGY are anticipated to be presented at a prominent scientific symposium in early 2008.


"These papers highlight the ongoing interest in evaluating new investigational uses of AGGRASTATR in the treatment of high risk cardiovascular disease patients," stated Medicure's President and CEO, Albert D. Friesen, PhD. "We believe AGGRASTATR has significant untapped potential, and look forward to the presentation of new data from studies such as MULTI-STRATEGY in the coming year."


Medicure acquired the exclusive U.S. rights to AGGRASTATR, in August 2006.


Important Information About AGGRASTATR AGGRASTATR was approved by the Food and Drug Administration on May 14, 1998.

AGGRASTATR, in combination with heparin, is indicated for the treatment of acute coronary syndrome, including patients who are to be medically managed and those undergoing percutaneous transluminal coronary angioplasty (PTCA) or atherectomy. In this setting AGGRASTATR has been shown to decrease the rate of a combined endpoint of death, new myocardial infarction or refractory ischemia/repeat cardiac procedure. AGGRASTATR has been studied in a setting that included aspirin and heparin.

AGGRASTATR is contraindicated in patients with known hypersensitivity to any component of the product; active internal bleeding or a history of bleeding diathesis within the previous 30 days; or a history of intracranial hemorrhage, intracranial neoplasm, arteriovenous malformation, or aneurysm. Other contraindications to AGGRASTATR include: a history of thrombocytopenia following prior exposure to AGGRASTATR; history of stroke within 30 days or any history of hemorrhagic stroke; major surgical procedure or severe physical trauma within the previous month; history, symptoms, or findings suggestive of aortic dissection. AGG
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
2. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Protox Announces Positive Clinical Data from Prostate Cancer Study
4. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
5. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
6. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
7. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
8. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
9. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
10. Chi-Med Announces Positive Phase II Proof-of-Concept Data for HMPL-004 in Ulcerative Colitis
11. Alkermes Announces Positive Results from Phase 1/2 Clinical Study of ALKS 29
Post Your Comments:
(Date:8/27/2014)... Varian Medical Systems (NYSE: VAR) today broke ground on ... Lake City manufacturing facility and allow for the ... to ultimately create 1,000 new full time jobs ... " Utah is home to hardworking ... can be credited with Varian,s success in the manufacturing of ...
(Date:8/27/2014)... DALLAS , August 27, 2014 ... "Dental Equipment Market By Products (Dental Radiology, CAD/CAM, Dental Chairs, ... 2019" published by MarketsandMarkets, the global Dental Equipment Market ... from $5,416.3 million in 2014, growing at a ... Browse 95 market data tables and 61 ...
(Date:8/27/2014)... York , August 27, 2014 ... United States  Laparoscopes Market Outlook to 2020. ... provides key market data on the United States ... of US dollars, volume (in units) and average prices ... Tip Video Laparoscopes and Flexible Tip Video Laparoscopes), Robotic ...
Breaking Medicine Technology:Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 2Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 3Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 4Dental Equipment Market Worth $7,138.9 Million by 2019 2Dental Equipment Market Worth $7,138.9 Million by 2019 3United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 2United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 3United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 4United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 5
... , CORALVILLE, Iowa, Dec. 16 Vivakor, ... Development agreement with Baker Consulting out of Walnut Creek, ... of South Florida. Baker Consulting has been retained ... assisting the company with its recently reported acquisition strategy. ...
... Dec. 16 Naurex Inc., a new clinical stage company ... on its novel GFPA NMDA receptor modulators, today announced that ... lead compound GLYX-13 and has successfully dosed the first subjects ... agonist (GFPA) selective modulator of the NMDA receptor, is initially ...
Cached Medicine Technology:Vivakor Signs Business Development Agreement With Baker Consulting 2Naurex Inc. Initiates Phase I Clinical Trial of its Novel Mechanism NMDA Modulator GLYX-13 in Treatment-Resistant Depression 2Naurex Inc. Initiates Phase I Clinical Trial of its Novel Mechanism NMDA Modulator GLYX-13 in Treatment-Resistant Depression 3
(Date:8/27/2014)... 28, 2014 BRIC Laparoscopes Market Outlook ... provides key market data on the BRIC Laparoscopes market. ... volume (in units) and average prices (in US dollars) ... and Flexible Tip Video Laparoscopes), Robotic Surgical Systems and ... of advantages to the patient with laparoscopic surgery versus ...
(Date:8/27/2014)... play a key role in inflaming blood vessels and ... study at UCLA demonstrates that they may also contribute ... the small blood vessels in the lungs. , Using ... mimicking part of the main protein in high-density lipoprotein ... production of oxidized lipids in pulmonary hypertension. They also ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 Dr. ... Vision Center see multitudes of patients suffering from impaired ... and Cataract vision correction surgery . Recently, Dr. ... glaucoma information during an eye exam and also online. ... the top five myths about glaucoma. , 1)    Myth: People ...
(Date:8/27/2014)... 27, 2014 The federal judge overseeing ... has extended the deadline for plaintiffs to enroll in ... Order issued by U.S. District Judge David Katz of ... in the DePuy ASR Settlement Program must do so ... ASR Hip Implant Products Liability Litigation – MDL 2197) ...
(Date:8/27/2014)... The extensive polling of 970 ... research group Black Book Rankings uncovers several alarming ... supplied or built to care for even a ... annual survey to gain stakeholder insight into the ... and emergency preparedness systems,” said Doug Brown, Managing ...
Breaking Medicine News(10 mins):Health News:Laparoscopes & Endoscopic Reprocessors Market in BRIC (Brazil, Russia, India & China) to 2020 Report Available at RnRMarketResearch.com 2Health News:Laparoscopes & Endoscopic Reprocessors Market in BRIC (Brazil, Russia, India & China) to 2020 Report Available at RnRMarketResearch.com 3Health News:Laparoscopes & Endoscopic Reprocessors Market in BRIC (Brazil, Russia, India & China) to 2020 Report Available at RnRMarketResearch.com 4Health News:Protein in 'good cholesterol' may be a key to treating pulmonary hypertension 2Health News:Renowned Eye Surgeon Dr. Stewart Shofner Debunks Top Five Myths About Glaucoma 2Health News:Renowned Eye Surgeon Dr. Stewart Shofner Debunks Top Five Myths About Glaucoma 3Health News:Renowned Eye Surgeon Dr. Stewart Shofner Debunks Top Five Myths About Glaucoma 4Health News:DePuy ASR Settlement Enrollment Deadline Extended Until September 30, 2014, Bernstein Liebhard LLP Reports 2Health News:DePuy ASR Settlement Enrollment Deadline Extended Until September 30, 2014, Bernstein Liebhard LLP Reports 3Health News:American Hospitals Are Vastly Unprepared for Ebola Patients, Reveals Black Book™ Survey of Emergency Physicians, Nurses and Infection Control Practitioners 2Health News:American Hospitals Are Vastly Unprepared for Ebola Patients, Reveals Black Book™ Survey of Emergency Physicians, Nurses and Infection Control Practitioners 3Health News:American Hospitals Are Vastly Unprepared for Ebola Patients, Reveals Black Book™ Survey of Emergency Physicians, Nurses and Infection Control Practitioners 4
... the Doubletree Hotel in Oak Brook ... 23 The Perinatal Nursing Advisory Council and the March of ... lactation consultants, and the community to the March of Dimes ... Oak Brook, Illinois. All healthcare professionals caring for moms ...
... retinoid tretinoin not the culprit , , FRIDAY, Jan. 23 (HealthDay ... that was tried as a possible skin cancer preventative in ... of several veterans participating in that research. , The ... risk of death was seen in those using retinoid tretinoin ...
... contradicts belief that death rate associated with condition has ... death rate for patients with acute respiratory distress syndrome ... that contradicts the common belief there,s been a steady ... , The researchers reviewed studies conducted between 1984 and ...
... inflammatory bowel disease have higher concentrations of folate in their blood than ... the University of California, San Francisco and UC Berkeley. The findings bring ... to folate - also known as folic acid - deficiency. , ... ...
... Ohio, Jan. 23 Patricia A. Furlong, Founding ... (PPMD), the largest non-profit organization in the United ... muscular dystrophy (Duchenne), announced the one year anniversary ... resources and needs of the Duchenne and Becker ...
... 23 Heartland Information Services,( www.heartlandis.com ), headquartered ... outsourced transcription companies in a report released in ... firm,( www.KLASresearch.com ). In their report, Top 20 ... 2008, Heartland moved up for the third year ...
Cached Medicine News:Health News:March of Dimes 34th Annual Perinatal Conference For Nurses, Health Educators, Social Workers and Other Healthcare Pros Caring for Moms and Babies 2Health News:Acne Cream Not Linked to Raised Death Risk 2Health News:Acne Cream Not Linked to Raised Death Risk 3Health News:Acute Respiratory Distress Syndrome as Deadly as Ever 2Health News:Children with Inflammatory Bowel Disease Have Surprisingly High Folate Levels, Study Finds 2Health News:Children with Inflammatory Bowel Disease Have Surprisingly High Folate Levels, Study Finds 3Health News:Children with Inflammatory Bowel Disease Have Surprisingly High Folate Levels, Study Finds 4Health News:DuchenneConnect Celebrates One Year Anniversary 2Health News:DuchenneConnect Celebrates One Year Anniversary 3Health News:DuchenneConnect Celebrates One Year Anniversary 4Health News:Heartland Information Services Moves Up to 2nd Place in National Survey for Outsourced Transcription 2
The Onar®Lp test system is an in vitro test for the qualitative diagnosis of legionella in clinical samples....
The Onar®Lp -QP test system is an in vitro test for the quantitative diagnosis of legionella in clinical samples....
Designed for OSA patients who have difficulty with conventional CPAP therapy, the ResMed SULLIVAN Comfort system is a solution for those who need an alternative to CPAP....
... an approach to treatment that ... pressure range to 25 cm ... treat patients with severe OSA. ... integrated humidification and built-in Encore® ...
Medicine Products: